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Background: Influenza is a segmented negative strand RNA virus. Each RNA segment is encapsulated by influenza
nucleoprotein and bound by the viral RNA dependent RNA polymerase (RdRP) to form viral ribonucleoproteins
responsible for RNA synthesis in the nucleus of the host cell. Influenza transcription results in spliced mRNAs (M2
and NS2), intron-containing mRNAs (M1 and NS1), and intron-less mRNAs (HA, NA, NP, PB1, PB2, and PA), all of
which undergo nuclear export into the cytoplasm for translation. Most cellular mRNA nuclear export is Nxf1-mediated,
while select mRNAs utilize Crm1.
Methods: Here we inhibited Nxf1 and Crm1 nuclear export prior to infection with influenza A/Udorn/307/1972(H3N2)
virus and analyzed influenza intron-less mRNAs using cellular fractionation and reverse transcription - quantitative
polymerase chain reaction (RT-qPCR). We examined direct interaction between Nxf1 and influenza intron-less
mRNAs using immuno purification of Nxf1 and RT-PCR of associated RNA.
Results: Inhibition of Nxf1 resulted in less influenza intron-less mRNA export into the cytoplasm for HA and NA
influenza mRNAs in both human embryonic kidney cell line (293 T) and human lung adenocarcinoma epithelial
cell line (A549). However, in 293 T cells no change was observed for mRNAs encoding the components of the viral
ribonucleoproteins; NP, PA, PB1, and PB2, while in A549 cells, only PA, PB1, and PB2 mRNAs, encoding the RdRP,
remained unaffected; NP mRNA was reduced in the cytoplasm. In A549 cells NP, NA, HA, mRNAs were found associated
with Nxf1 but PA, PB1, and PB2 mRNAs were not. Crm1 inhibition also resulted in no significant difference in PA, PB1,
and PB2 mRNA nuclear export.
Conclusions: These results further confirm Nxf1-mediated nuclear export is functional during the influenza life
cycle and hijacked for select influenza mRNA nuclear export. We reveal a cell type difference for Nxf1-mediated
nuclear export of influenza NP mRNA, a reminder that cell type can influence molecular mechanisms. Importantly, we
conclude that in both A549 and 293 T cells, PA, PB1, and PB2 mRNA nuclear export is Nxf1 and Crm1 independent.
Our data support the hypothesis that PA, PB1, and PB2 mRNAs, encoding the influenza RdRP, utilize atypical mRNA
nuclear export.
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Influenza A virus remains a health menace and while yearly
statistics vary, ~36,000 deaths and ~220,000 hospitaliza-
tions are attributed to influenza each year (mean value) in
the United States [1]. Moreover, the rapidly evolving nature
of this segmented RNA virus leads to the emergence of
new, unseen subtypes, which have potential to cause a
pandemic. Influenza pandemics have occurred at three* Correspondence: lnewcomb@csusb.edu
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unless otherwise stated.times in the last century (1918, 1957 and 1968) and once
in the current century (2009). Fortunately, the 2009 novel
H1N1 influenza virus proved not as pathogenic as initially
expected, resulting in fewer deaths than predicted. How-
ever, the high transmissibility saw the novel H1N1 readily
sweep the globe and resulted in a high global economic
burden [2]. Findings that the highly pathogenic H5N1
avian influenza is able to evolve increased transmissibility
in the ferret model [3,4], has again emphasized the real
possibility that a mutation or recombination event could
result in the emergence of a highly pathogenic and easilyLtd. This is an Open Access article distributed under the terms of the Creative
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deadly pandemic. Greater understanding of the molecular
mechanisms of influenza replication will facilitate the
ability to identify novel antiviral targets and develop
effective antiviral therapies.
Influenza is a segmented negative strand RNA virus. Each
RNA segment is encapsulated by influenza nucleoprotein
(NP) and bound by the viral RNA dependent RNA poly-
merase (RdRP) to form viral ribonucleoproteins (vRNPs)
responsible for RNA transcription. Unlike most negative
strand RNA viruses, which transcribe RNA in the cyto-
plasm, influenza transcribes its mRNA in the nucleus.
Transcription is primed with a capped 12–15 nucleotide
RNA excised from nascent cellular mRNAs by the RdRP in
a process termed “cap-snatching” [5] and polyadenylated by
reiterative copying at a poly U stretch near the 5’ end of the
vRNA template [6]. Two viral transcripts, M and NS, are
spliced to generate alternative mRNAs. Virus replication
requires the nuclear export of spliced mRNAs (M2 and
NS2), intron-containing mRNAs (M1 and NS1), and
intron-less mRNAs (HA, NA, NP, PB1, PB2, and PA).
The major structure involved in nuclear trafficking is
an assembly of nucleoporins located within the nuclear
envelope termed the Nuclear Pore Complex (NPC). Large
molecular weight complexes require nuclear export signals
to export through the NPC. RNAs are transported by
interaction with proteins. Studies of retroviral mRNA
nuclear export have led to our understanding of two
distinct host mRNA nuclear export pathways, represented
by the proteins Crm1 and Nxf1. Complex retroviruses
such as HIV encode viral Rev protein, which binds the
Rev-responsive element (RRE) found within the introns of
intron-containing completely un-spliced and partially
spliced viral mRNAs, and assists in the export of these
viral mRNAs from the nucleus [7]. Rev contains the first
described nuclear export signal (NES) which interacts
with host Crm1 to export Rev, along with the bound viral
intron containing mRNA, to the cytoplasm [8]. Simple
retroviruses such as Mason-Pfizer monkey virus (MPMV)
encode an RNA structure within introns termed the
constitutive transport element (CTE), which was used
to identify host nuclear export factor 1 (Nxf1, also
called TAP) as a cellular mRNA nuclear export factor [9].
Over-expression of this RNA element blocks most cellu-
lar mRNA nuclear export but not Rev dependent mRNA
nuclear export [10]. Conversely, a mutant nucleoporin,
which inhibits Crm1, blocks Rev dependent RNA export
but not bulk cellular mRNA export or CTE dependent
export [11]. Therefore, the two host cellular proteins,
Crm1 and Nxf1, represent two separate mRNA nuclear
export pathways.
Research on the mechanisms of influenza mRNA
nuclear export is insufficient and results contradictory.
RNAi screening in drosophila cells identified Nxf1 as anessential host factor for influenza mRNA nuclear export
[12]. Additional studies provide evidence of a role for
host Nxf1 in export of some but not all influenza
mRNAs [13,14]. In contrast, another report concludes
that influenza NS1 protein inhibits host Nxf1 nuclear
export to block expression of host antiviral mRNAs
such as IFN mRNAs [15]. The latter paper suggests
influenza mRNA nuclear export is not Nxf1-mediated,
but rather Crm1-mediated. While Crm1 nuclear export
is utilized by influenza virus for export of viral ribonu-
cleoproteins (vRNPs) during virion assembly [16], reports
support host Crm1 is not used by any influenza mRNAs
for export from the nucleus [13,14,17,18]. The published
studies were performed in kidney cells, either Madin-
Darby canine kidney cell line (MDCK), baby hamster
kidney cell line (BHK), and/or human embryonic kidney
cell line (293 T). Given that influenza virus infects cells
of the respiratory tract, human lung adenocarcinoma
epithelial cell line (A549) are likely a better model cell
line for studies of influenza infection. Therefore, we set
out to examine influenza viral mRNA export in human
lung adenocarcinoma epithelial cell line (A549).
Here we report our results on the role of Nxf1 and
Crm1 in influenza intron-less mRNA nuclear export
(HA, NA, NP, PB1, PB2, and PA mRNAs). We utilized
both inhibition of Nxf1 or Crm1 and direct immuno
purification of Nxf1 along with associated RNAs. We
find influenza mRNA nuclear export is Nxf1-mediated
with the exception of the influenza RNA dependent
RNA polymerase encoding mRNAs; PA, PB1, and PB2.
Our results in A549 cells differed from our results and
published research obtained in 293 T cells [13] with respect
to the export of influenza NP mRNA. This led us to
conclude there is a cell type difference in Nxf1-mediated
NP mRNA nuclear export: in human lung adenocarcin-
oma epithelial cell line (A549) NP mRNA nuclear export
is Nxf1-mediated while in human embryonic kidney cell
line (293 T) NP mRNA nuclear export is Nxf1 independ-
ent. It is important to acknowledge cell type differences if
the larger goal is to translate data to application.
Although much research suggests Crm1 is not utilized
for influenza mRNA nuclear export [13,14,17,18], in light
of the revelation of a cell type difference, we readdressed
the role of Crm1 in influenza mRNA nuclear export in
A549 cells. Inhibition of Crm1 did not result in significant
inhibition of nuclear export of any influenza mRNAs ana-
lyzed. This led us to conclude that the influenza RNA
dependent RNA polymerase encoding mRNAs; PA, PB1,
and PB2, do not export the nucleus via the two defined
mRNA nuclear export pathways represented by Crm1 and
Nxf1, but instead use an atypical mRNA nuclear export
pathway. Defining this pathway will shed light on alternate
cellular mRNA nuclear export pathways and may lead to
the discovery of novel antiviral targets.
Larsen et al. Virology Journal 2014, 11:154 Page 3 of 11
http://www.virologyj.com/content/11/1/154Results and discussion
Inhibition of Nxf1-mediated nuclear export via expression
of dominant negative Nxf1 results in decreased virus
production and cytoplasmic reduction of select influenza
mRNAs
We inhibited Nxf1-mediated nuclear export by expression
of a dominant negative Nxf1 protein encoding alanine
substitutions at residues 593–595 within the nuclear
export signal (NES), rendering a dominant negative effect
on Nxf1-mediated nuclear export [19]. We expressed
dominant negative Nxf1 in A549 cells, with transfection
efficiency ~70% as monitored by co-transfection with
eGFP. We detect less virus production in cells inhibited
for Nxf1-mediated nuclear export via expression of dom-
inant negative Nxf1 than control (Figure 1A). 48 hours
post transfection with DNA plasmids to express dominant
negative Nxf1, A549 cells were infected with influenza
A Udorn at MOI of 2.5 to assay single cycle infection.
After 1-hour incubation with virus inoculum, cells were
thoroughly washed and media samples collected. Collected
media was used in plaque assay to calculate virus titer.
Virus production was significantly inhibited at 12 hours
post infection in A549 cells expressing the dominant nega-
tive Nxf1 protein (Figure 1A). These results are consistent
with the notion that Nxf1 is required for optimal influenza
production during infection [12].
To examine viral mRNA expression and export, A549
cells were fractionated at 3.5 hours post infection and
proteins isolated from both the nuclear and cytoplasmic
fractions. Western blot confirms cellular fractionation as
SP1, a protein localized to the nucleus, is detected only
in the nuclear fraction, and Hsp90, a protein localized to
the cytoplasm, is detected only in the cytoplasmic fraction
(Figure 1B). RNA was isolated from the cytoplasmic
fraction and quantified using a nanospectrophotometer,
and equal concentrations of RNA were subject to reverse
transcription using oligo dT and gene specific PCR with
primers to amplify influenza genes. We show results from
three independent biological trials of RNA isolated from
the cytoplasmic fraction using both semi-quantitative
PCR, where product is taken over sequential cycles during
exponential amplification and examined via ethidium
bromide and gel electrophoresis, and triplicate quantita-
tive PCR, where product is assessed by SYBR Green at
each cycle and graphed relative to the control (uninhibited)
sample. In all trials our data revealed that while NP mRNA
expression in the cytoplasm was significantly decreased
in A549 cells with Nxf1-mediated export inhibited, the
polymerase encoding mRNAs, PA, PB1, and PB2 were
not significantly affected (Figure 1C and D).
Our data is both similar and different to one published
report [13], which concluded that early expressed mRNAs,
NP and PB2, were less dependent on Nxf1-mediated
nuclear export, with NP mRNA showing the leastdependency. To understand the discrepancy regarding
NP mRNA nuclear export, we addressed differences in
the experimental design to determine what could account
for the variance. In addition to different mechanism of
inhibition, both the cell type and influenza strain used
were different in our study. Therefore, we repeated our
experimental approach in both 293 T and A549 cells,
where we observed ~90% and ~70% transfection efficiency
respectively, as monitored by co-transfection with eGFP.
Western blot demonstrates decent cellular fractionation
with tubulin, primarily in the cytoplasmic fraction and
SP1 or TAT-SF1, nuclear localized proteins, detected in
the nuclear fraction (Figure 2A). There is a background
signal of unconfirmed identity, which migrates slightly
below tubulin, detected in the 293 T nuclear fractions
probed with anti-tubulin. We show triplicate RT-qPCR of
isolated cytoplasmic RNA from two independent biological
trials in each cell type to demonstrate that while NP mRNA
nuclear export was Nxf1-mediated in A549 cells, NP
mRNA nuclear export had no dependence on Nxf1 in
293 T cells (Figure 2B). Our studies reveal there is a cell
type difference for influenza NP mRNA nuclear export. It
is important to report and acknowledge cell type molecular
differences to facilitate the transition from basic research
to application. Further, our data support Nxf1-mediated
nuclear export is functional during influenza infection and
is important for optimal virus production.
Immuno-purification of Nxf1 in A549 cells reveals NP, HA,
and NA influenza viral mRNAs associate with Nxf1, while
PA, PB1, and PB2 mRNAs do not
To further support the use of Nxf1 for influenza NP
mRNA nuclear export but not polymerase encoding
mRNAs in A549 cells, we immuno purified Nxf1 and
examined associated RNAs. A549 cells were transfected
with DNA plasmid to express functional FLAG-tagged
human Nxf1 protein or FLAG-Vector control, express-
ing only the FLAG epitope [20]. Transfection efficiency
was ~70% in A549 cells as monitored by co-transfection
with eGFP. 48 hours post transfection cells were infected
at MOI of 2.5 for analysis of single cycle infection. Cells
were collected at 7 hours post infection and total protein
extracts prepared. The extracts were subject to immuno
affinity purification using anti-FLAG antibodies coupled
to beads. Samples were analyzed by Western blot to
confirm immuno purification of FLAG-Nxf1 (Figure 3A).
While the Western blot results show not all expressed
FLAG-Nxf1 was purified, as some FLAG-Nxf1 remains in
the supernatant (SUP), sufficient amounts of FLAG-Nxf1
were present in the immuno purified (IP) sample for ana-
lysis of co-associated mRNAs. RNA was isolated from
total extract and IP sample of infected cells expressing
FLAG-Nxf1 or FLAG-vector negative control. RNA was
analyzed with a nanospectrophotometer at absorbance
Figure 1 Expression of dominant negative Nxf1 decreases virus production and results in cytoplasmic reduction of select influenza
mRNAs. A549 cells were transfected with plasmid to express dominant negative Nxf1 (DN) or vector control (vec) and infected with influenza A
Udorn at 2.5 MOI 48 hours post transfection. A. Virus production at 12 hours post infection with influenza A Udorn. An asterisk indicates statistical
difference between cells transfected with DN-Nxf1 compared to vec-control. Data presented is from biological triplicate trials. B. Cells transfected with
DN-Nxf1 or vector for 48 hours and subsequently infected with influenza A Udorn at 2.5 MOI for 3.5 hours were fractionated. Cytoplasm and nuclear
protein fractions were separated by SDS-PAGE and subject to Western blot to detect SP1 and Hsp90. Shown is a representative blot from one biological
trial. C. RT-semi-qPCR of RNA isolated 3.5 hours post infection from the cytoplasm fraction. RNA was quantified and equal concentrations subject to RT
with oligo dT. Gene specific PCR was performed using primers to amplify NP, PA, PB1 and PB2 as indicated. Data show sequential PCR cycles from three
biological independent trials. D. RT-qPCR of RNA isolated from one of the above biological trials performed in triplicate. Delta Ct was calculated to
determine relative RNA expression. Raw CT values were analyzed in Microsoft Excel using 2ΔCt(average control- average treated). Standard error was obtained
by calculating the standard deviation of the sample set divided by the square root of the sample set size, and indicated using error bars. Significance
was determined using a two-tailed T-Test conducted in Microsoft Excel, and judging any p value less than .05 as significant, indicated by an asterisk.
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RNA from both the total and IP samples from both
FLAG-Nxf1 and FLAG-vector negative control were
subject to reverse transcription with oligo dT to gener-
ate cDNA of any associated polyadenylated RNAs. As
expected, we routinely recovered less RNA in the FLAG-
vector negative control IP compared to FLAG-Nxf1 IP.
Therefore, to use equal RNA concentrations we consist-
ently used a greater volume of sample recovered from the
FLAG-vector negative control IP, which still showed little/no non-specific association with the highly expressed
influenza mRNAs, strengthening the stringency of our
experiment (Figure 3B and C). Furthermore, given that
PCR is a very sensitive technique, which can amplify
trace quantities of cDNA, we included a total control
using 10% of cDNA from the total RNA sample; thus
representing 10% of the amount processed in the IP
sample. This provided an ~10% cut-off for interaction
detection; if 10% of total cDNA showed product at PCR
cycle 25 but the IP sample did not, we considered this
Figure 2 NP mRNA analysis reveals a cell type difference in dependence of Nxf1-mediated nuclear export. A549 and 293 T cells were
transfected with plasmid to express dominant negative Nxf1 (DN) or vector control (vec), infected with influenza A Udorn at 2.5 MOI 48 hours
post transfection, and fractionated 3.5 hours post infection. A. Cytoplasm and nuclear protein fractions were separated by SDS-PAGE and subject
to Western blot to detect SP1, TAT-SF1, or tubulin. Shown is a representative blot from one biological trial. B. RT-qPCR of RNA isolated from the
cytoplasm fraction. RNA was quantified and equal concentrations subject to RT with oligo dT. Gene specific PCR was performed using primers to
amplify NP, PA, PB1 and PB2 as indicated. Data shown is from two biological independent trials of more than 5 repeats, each trial performed in
triplicate PCR. Delta Ct was calculated to determine relative RNA expression. Raw CT values were analyzed in Microsoft Excel using 2ΔCt(average
control- average treated). Standard error was obtained by calculating the standard deviation of the sample set divided by the square root of the sample
set size, and indicated using error bars. Significance was determined using a two-tailed T-Test conducted in Microsoft Excel, and judging any
p value less than .05 as significant, indicated by an asterisk.
Figure 3 Nxf1 is associated with NP, HA, and NA influenza mRNAs in A549 cells. A549 cells were transfected with plasmid to express FLAG-Nxf1
or FLAG-Vector control and infected with influenza A Udorn at 2.5 MOI 48 hours post transfection. Cells were collected 7 hours post infection and total
extract prepared and subject to immuno purification using anti-FLAG antibody coupled to beads. Protein and RNA were isolated from total extract,
immuno purified beads, and supernatant. A. Protein from the immuno purified beads (IP) and supernatant (sup) were separated by SDS-PAGE and
subject to Western blot with anti-FLAG antibody to detect FLAG-Nxf1. Shown is a representative blot from one biological trial. B-C. RNA isolated from
IP and total samples was quantified and equal concentrations were subject to RT with oligo dT. Gene specific PCR was performed using primers to
amplify NP, PA, PB1, PB2, HA, and NA for 25 cycles. Data shown is from two representative trials of more than 5 repeats. In all cases the volume of
cDNA used in the PCR step was 1/10th that used in the IP samples, with the exception of NP amplification in B, where equal cDNA was used for total
and IP, and total samples are likely at saturation limit in end point PCR.
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show product we considered this Nxf1-associated. Given
Nxf1-mRNA is a dynamic interaction which only occurs
during the act of mRNA nuclear export, ~10% of the
mRNA showing interaction was reasoned to be an
appropriate cut-off to avoid detection of false positives
which could occur given the sensitivity of PCR. We find
that while HA, NA, and NP mRNAs were specifically
associated with FLAG-Nxf1; PA, PB1, and PB2 mRNAs
were not (Figure 3B and C). Our results are both in
agreement and disagreement with published studies
[14], which conclude that NA, M1, and PB1 mRNAs
associate with Nxf1 (also called TAP). Again there are
many variables that could account for the discrepancy
including virus subtype (Udorn vs PR8) and cell line uti-
lized (A549 vs MDCK, Madin-Darby canine kidney).
Our experiments demonstrate a specific and physical
association of HA, NA, and NP influenza mRNAs with
Nxf1 in A549 cells but no association with PA, PB1, and
PB2 mRNAs. These immuno purification data are in
agreement with our results obtained by inhibition of
Nxf1. Together our data conclude that HA, NA, and NP
mRNA nuclear export is Nxf1-mediated in A549 cells,
while the polymerase encoding mRNAs, PA, PB1, and
PB2, use an Nxf1-independent nuclear export mechanism.
Influenza NS1 protein also associates with Nxf1/RNA
immuno purified complexes
We confirm the reported influenza NS1 - Nxf1 protein
interaction observed in kidney cells [14,15] in A549 cells
(Figure 4). This interaction is speculated to inhibit Nxf1
nuclear export as a mechanism to boost host shut off ofFigure 4 Nxf1 is associated with influenza NS1 protein in A549
cells. A549 cells were transfected with plasmid to express FLAG-Nxf1
or FLAG-Vector control and infected with influenza A Udorn or mock
infected at 48 hours post transfection. Cells were collected 7 hours
post infection and total extract was prepared and subject to immuno
purification using anti-FLAG antibody coupled to beads. Proteins from
the total extract (tot), immuno purified beads (IP), and supernatant
(sup), were separated by SDS-PAGE and subject to Western blot with
anti-FLAG antibody to detect FLAG-Nxf1 and anti-NS1 (Udorn) to
detect influenza NS1 protein. Shown is a representative blot from
one biological trial.antiviral gene expression [15] and enhance intron-less
mRNA nuclear export [14]. It is possible NS1-Nxf1 pro-
tein interaction has a dual role; perhaps by facilitating
and/or regulating select influenza mRNA nuclear export,
host mRNA nuclear export is simultaneously inhibited.
However, it is known from commonly utilized reconstituted
vRNP assays that only influenza NP and RdRP (PA, PB1,
PB2) proteins are required for mRNA production and
subsequent protein expression from all vRNA templates,
demonstrating NS1 is not required for efficient influenza
mRNA nuclear export. On the other hand, NS1 has been
speculated to play regulatory roles in influenza mRNA
synthesis [21], splicing [22], nuclear export [23], and
translation [24]. However, NS1 deletion viruses are viable
in interferon (IFN) deficient Vero cells, underscoring the
main function of influenza NS1 as an IFN antagonist [25].
In addition, host mRNA transcription is targeted for
shut off by influenza at a minimum of two steps prior to
mRNA nuclear export; loss of the 5’ cap structure on
nascent mRNAs due to influenza ‘cap-snatching’ [5], and
inhibition of host mRNA polyadenylation due to influenza
NS1 interaction with host cleavage and polyadenylation
specificity factor 30 kDa subunit (CPSF30) [26]. While it
is unclear how much contribution to host shut off is due
to NS1-Nxf1 interaction, viruses often employ multiple
targets to counter the host antiviral defenses. While we do
not yet completely understand the role of the NS1-Nxf1
protein interaction, it is clear that Nxf1-mediated nuclear
export is functional during the influenza life cycle for
nuclear export of at least some select influenza mRNAs
and required for optimal influenza replication and virus
production.
Leptomycin B treatment inhibits virion production but
not influenza PA, PB1, or PB2 mRNA nuclear export in
A549 cells.
While published data suggests no influenza mRNAs
utilize Crm1 for nuclear export [13,14,17,18], these studies
were carried out in kidney cell lines. Given the cell type
difference regarding NP mRNA nuclear export and the
lack of analysis of the role of Crm1 in a lung cell line, we
readdressed this question in A549 cells. Consistent with
the previous studies, we found no role for Crm1 in influ-
enza mRNA nuclear export in A549 cells. After the initial
virus attachment period, cells were treated with 10 nM
LMB during viral infection at MOI of 1.4 or 2.8. To assess
inhibition of Crm1 nuclear export, cells were washed well
after 1 hour of incubation with virus inoculum and media
samples taken. HA assay confirms no detectable virions
are produced in cells treated with LMB in contrast to
untreated cells, which produced virions detectable by HA
(Figure 5A). This result suggests Crm1-mediated nuclear
export is inhibited in the LMB treated samples because
vRNP nuclear export during virion assembly requires
Figure 5 Leptomycin B treatment does not alter cytoplasmic influenza PA, PB1, or PB2 mRNA in A549 cells. A549 cells were infected
with influenza A and virus allowed to adhere for 1 hour at which time virus inoculum was removed and replaced with media containing 10nM
leptomycin B (LMB) to inhibit Crm1-mediate nuclear export or untreated media as control. A. Media samples from mock infected, LMB treated
and untreated infected cells (top rows infected at MOI 1.4, bottom row infected at 2.8 MOI) were collected 36 hours post infection and subject
to HA assay using two-fold dilutions. B. Infected LMB treated and untreated cells were fractionated at 3.5 hours post infection. Cytoplasm and nuclear
protein fractions were separated by SDS-PAGE and subject to Western blot to detect Nxf1 and Hsp90. C. RT-qPCR of RNA isolated from the cytoplasm
fraction 3.5 hours post infection. RNA was quantified and equal concentrations subject to RT with oligo dT. Gene specific PCR was performed using
primers to amplify PA, PB1, PB2, HA, and NP as indicated. Data shown is from one biological trial performed in triplicate. Delta Ct was calculated to
determine relative RNA expression. Raw CT values were analyzed in Microsoft Excel using 2ΔCt(average control- average treated). Standard error was obtained
by calculating the standard deviation of the sample set divided by the square root of the sample set size, and indicated using error bars. Significance was
determined using a two-tailed T-Test conducted in Microsoft Excel, and judging any p value less than 0.05 as significant, no genes showed statistical
difference in relative expression of RNA. PB2 p value was 0.105.
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influenza mRNA nuclear export, cells were collected at
3.5 hours post infection, fractionated, and protein isolated
from both nuclear and cytoplasmic fractions. Western
blot confirms cellular fractionation as Nxf1, a protein
localized to the nucleus, is detected only in the nuclear
fraction, and Hsp90, a protein localized to the cytoplasm, is
detected only in the cytoplasmic fraction (Figure 5B). RNA
was isolated from the cytoplasmic fraction, quantified using
a nanospectrophotometer, and equal concentrations were
subject to reverse transcription using oligo dT and gene
specific quantitative PCR in triplicate with primers to
amplify influenza genes. We found no significant difference
between LMB treated and untreated samples for cytoplas-
mic levels of influenza HA, NP, PA, PB1, and PB2 mRNAs
(Figure 5C). However, cytoplasmic PB2 mRNA was ~25%
decreased in LMB treated cells with a p-value of 0.105,
which may represent some dependency on Crm1 nuclear
export but was not deemed significant with a cut off of
p < 0.05. Still, from this experiment we conclude that
Crm1 is not utilized for intron-less influenza mRNA
nuclear export in A549 cells. Together our results reveal
that the influenza polymerase encoding mRNAs, PA, PB1,
and likely PB2, use neither the major cellular mRNA
nuclear export factor, Nxf1, nor the alternate Crm1 nuclear
export factor for mRNA nuclear export in human lung
adenocarcinoma epithelial cell line (A549).
Conclusion
There are three main conclusions from our research
results. The first is that Nxf1-mediated nuclear export isrequired for optimal influenza virus production in all cell
types examined. When Nxf1-mediate nuclear export is
inhibited by expression of dominant negative Nxf1 protein
there is less nuclear export of select influenza mRNAs
and less virus production. These data suggest that Nxf1-
mediated nuclear export needs to be functional for optimal
influenza replication. Further, select influenza mRNAs
were found associated with Nxf1 in the cell, strongly
supporting use of Nxf1-mediated nuclear export by these
select viral mRNAs.
The second main conclusion is the recognition that
model cell type can influence molecular mechanisms of
influenza infection. We clearly demonstrate that NP mRNA
nuclear export is Nxf1-mediated in A549 cells but Nxf1-
independent in 293 T cells. This conclusion is important to
properly assess research results for relevance to application.
While 293 T cells are routinely used in research because of
excellent ability to take up DNA, they are kidney cells and
thus may not be the best human model cell line to study
the molecular mechanism of the respiratory influenza A
virus; A549 lung cells may represent a better model. Our
study is a needed reminder that cell type can influence
molecular mechanisms and this must be taken into consid-
eration when analyzing, compiling, and comparing data.
The third and in our opinion most important main
conclusion is that the polymerase encoding mRNAs, PA,
PB1, and likely PB2, appear to use neither defined host
mRNA nuclear export pathway in both cell types exam-
ined. This is an exciting result as it implies these viral
mRNAs utilize an uncommon mRNA nuclear export
pathway. While there are other RNA nuclear export
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Exportin 5 to export pre-micro-RNAs [28], these factors
have not as yet been implicated in export of mRNAs,
viral or host. It may be that influenza has hijacked one
of these non-coding RNA export pathways to export
viral mRNAs. Further, Nxf1 is a member of a family of
nuclear export factors, and it could be that influenza
polymerase encoding mRNAs have hijacked a less char-
acterized member of this family. It is also possible that the
influenza polymerase encoding mRNAs utilize an as yet
unidentified and uncharacterized nuclear export pathway
which likely function in atypical mRNA nuclear export
pathway(s) and may represent feasible targets for future
development of innovative antiviral therapies. Identifica-
tion of the host factors that participate in the nuclear
export of influenza PA, PB1, and PB2 mRNAs is a goal of
our future research.
Methods
Cells, virus, plasmids, LMB, and antibodies
293 T human embryonic kidney cell line, A549 human
lung adenocarcinoma epithelial cell line, and MDCK
Madin-Darby canine kidney cell line were purchased
from ATCC American tissue culture collection and
maintained at 37°C with 5% CO2 in DMEM with 10%
FBS. Influenza A/Udorn/307/1972(H3N2) was generated
from 12 plasmids using reverse genetics as described
[29]. The plasmids required for reverse genetics were
kindly provided by R. Krug. Plasmids encoding dominant
negative DN - Nxf1 (TapA17) was kindly provided by B.
Cullen [19] and plasmid encoding FLAG-Nxf1 was kindly
provided by J. Steitz [20]. Plasmid DNA was purified using
QIAGEN maxi or mini prep kit per manufacturers proto-
col. Leptomycin B (LMB) was purchased from Fisher. α-
Tubulin, α-SP1, α-HSP90, α-NXF1, and α-FLAG were
purchased from Abcam and used per manufacturers
instructions. α-NS1 Udorn was kindly provided by R. Krug.
Secondary HRP coupled α-Mouse and α-Rabbit were
purchased from Pierce and used per manufacturer’s
instructions.
Transfection
293 T or A549 cells were grown to approximately 70%
confluency in 100 mm dishes or 6-well plates depending
on experiment.
pcDNA plasmids encoding FLAG-NXF1 (10 μg) and
FLAG-Vector (9 μg) with eGFP (1 μg), or DN-Nxf1
(10 μg) and CMV (9 μg) with eGFP (1 μg) were trans-
fected into cells (100 mm dish) using Mirus transfection
DNA to reagent at a ratio of 1:3 (293 T cells) or 1:2
(A549 cells). eGFP was used to monitor transfection
efficiency, which was ~70% in A549 cells and ~90% in
293 T cells. 48 hrs post transfection one set was mock
infected and the other infected at MOI of 2.5.LMB treatment
Cells were allowed to incubate with viral inoculum (MOI
1.4 or 2.8) for 1 hour; after attachment viral inoculum
was removed and 10nM LMB was added along with the
incubation media in treated samples for the remainder
of influenza infection period.
Influenza A infection
Cells were infected with MOI of 1.4, 2.5, or 2.8 as indi-
cated. Cells were first washed with PBS and overlaid
with viral inoculum for 1 hour with gentle shaking every
15 minutes to ensure cells did not dry out and virus
attachment occurred. After 1 hour virus inoculum was
removed and replaced with media containing 2.5% FBS.
For experiments where virion or virus production was
assessed, cells were washed numerous times prior to
addition and sampling of media. Furthermore, a control
sample was taken at this point to ensure minimal/no
virus left behind from inoculum. For examination of
mRNA nuclear export under conditions of Nxf1 or Crm1
inhibition, cells were collected at 3.5 hours post infection.
For examination of direct Nxf1-mRNA interaction, cells
were collected at 7 hours post infection.
Plaque and HA assays
Serial dilutions of media samples were subject to standard
plaque or HA assay. For plaque assay, media from tripli-
cate samples were diluted and used to infect confluent
MDCK cells. Titers from triplicate trials were averaged
and standard error was obtained by calculating the stand-
ard deviation of the sample set divided by the square root
of the sample set size, and indicated using error bars.
Significance was determined using a two-tailed T-Test
conducted in Microsoft Excel, and judging any p value less
than .05 as significant. For HA assay two-fold dilutions of
media was mixed with chicken red blood cells.
Cellular fractionation and isolation of protein and RNA
At 3.5 hours post infection, cells were pelleted by centri-
fugation and cellular pellets were washed in 5X volume
of cell pellet with Reticulate Standard Buffer (RSB:
10 mM Tris HCl pH7.5, 10 mM KCl, 1.5 mM MgCl2)
containing protease and RNase inhibitors. Cells were
then re-suspended in RSB at 10X the volume of the cell
pellet and incubated on ice for 10 minutes. NP-40 was
added to a final concentration of 0.2% to disrupt plasma
membranes. Visual inspection of the cells before and
after addition of NP-40 ensured burst plasma membranes
and intact nuclei. Nuclei were pelleted by centrifugation
at 300×g for 8 minutes at 4°C. The cytoplasmic extract
was collected and the nuclear pellet was re-suspended
in Dignam Buffer C without glycerol (20 mM HEPES
pH 7.9, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA)
and containing protease and RNase inhibitors, to release
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were clarified from debris by high-speed centrifugation for
10 minutes at 4°C. An equal amount of 20 mM HEPES
pH 7.9, 0.2 mM EDTA was added to the nuclear extract
to reduce the total NaCl and MgCl2 concentrations. This
was used as cytoplasmic and nuclear protein extracts.
To isolate RNA, equal volume of Phenol/Chloroform/
Isoamyl alcohol (25:24:1) was added to a portion of the
cytoplasmic and nuclear fractions. Samples were vortexed
4 times for 10 seconds and placed on ice in between.
Samples were centrifuged at 13,000 RPM for 10 minutes
at 4°C. Aqueous layer was collected and 0.5 volume
NH4OAc (7.5 M) and 2X volume 100% EtOH was added
and RNA was allowed to precipitate overnight at −80°C.
Samples were centrifuged at 13,000 RPM for 20 minutes
at 4°C. Pellet was washed in 75% EtOH and centrifuged
at 13,000 RPM for 5 minutes at 4°C. EtOH was removed
and pellet was allowed to air dry for 10 minutes and
resuspended in 10 mM Tris in DEPC H2O; amount
dependent on size of RNA pellet. RNA was quantified
using a nanospectrophotometer and absorbance at 260.
Total extract preparation for immunopurification and
associated RNA isolation
For immuno purification experiments, cell pellets were
resuspended in 1 mL Sonication Buffer (100 mM Tris HCl
pH 7.5, 100 mM NaCl, 2.5 mM MgCl2, 0.5% Triton ×-100)
containing protease and RNase inhibitors. Cells were lysed
using Fisher Scientific Sonic Dismembrator for 30 pulses at
30%, output 3–4. Sonicated materials were loaded onto a
30% sucrose cushion (30% Sucrose, 10 mM Tris HCl
pH 7.5, 100 mM NaCl, 2.5 mM MgCl2) and centrifuged at
4000 RPM for 15 minutes at 4°C to clarify total protein
extract.
Immunopurification
A portion of total protein extract was incubated with α-
FLAG antibody (Stratagene) (1:50) and protease inhibitors
for 1 hour at 4°C. Extracts were then incubated with PA/G
sepharose beads washed with sonication buffer and contain-
ing protease inhibitors, at 4°C overnight. The samples were
then spun for 8 seconds at 13,000 RPM at 4°C. Supernatant
was collected. Beads were washed 3 times in 1 mL sonic-
ation buffer with RNase inhibitors. With each wash samples
were then centrifuged for 8 seconds at 13,000 RPM at 4°C.
1/3 of the immuno purification from last wash was saved
for protein analysis, and 2/3 was saved for RNA isolation.
RNA isolation
Samples were first subject to protease degradation by
incubation with protease K and equal volume of Phenol/
Chloroform/Isoamyl alcohol (25:24:1) was added to the
resuspended bead immunopurification sample and totalextract and samples processed as previously described
above.
SDS-PAGE and Western Blot
Protein extracts were separated by SDS-10% PAGE.
Proteins were transferred to nitrocellulose using Fisher
semi-dry blot apparatus and probed with primary and
HRP-conjugated secondary antibodies as indicated. Pierce
ECL reagents were used to detect HRP conjugated
secondary antibody. Blots were developed using the
Chemi-Hi setting on the ChemiDoc™ XRS (BioRad) sys-
tem and digital images were obtained using Quantity One
software. Digital images were exported as raw data TIFF
files and image prepared using Adobe Photoshop to
crop photos and adjust exposure, and Adobe Illustrator
to add figure text labels.
Reverse transcription – PCR
RNA was first quantified by spectrophotometry and
separated on a 1% bleach/1% agarose gel to observe
rRNA in total and cytoplasmic RNA preparations. For
inhibition experiments, 1 μg cytoplasmic RNA was subject
to reverse transcription using Promega AMV reverse
transcription system per manufacturer’s protocol with
oligo dT as primer. For immuno purification experiments,
150-500 ng RNA was subject to reverse transcription
depending on RNA recovery; however in all cases
equivalent RNA concentration was used for all samples
in the RT step.
End point and semi-quantitative PCR
For analysis of mRNAs associated with Nxf1, 10% cDNA
from total samples relative to 100% cDNA from IP was
used for PCR (for example 1ul total and 10ul IP). For
analysis of mRNA in cells inhibited for Nxf1-mediate
nuclear export, equal volume cDNA was subject to gene
specific PCR. For analysis of mRNAs associated with
Nxf1 samples were taken at cycle 25. For analysis of
mRNA in cells inhibited for Nxf1-mediate nuclear export
samples were taken at sequential cycles as indicated to
confirm analysis within the PCR exponential amplification
curve. Samples were observed by ethidium bromide 1%
agarose gel electrophoresis.
Primers for end point and semi-quantitative PCR:
NP (forward - CCAGAAGAAGTGTCCTTCCG,
reverse - CGTACTCCTCTGCATTGTCTCC),
PB1 (forward - CCCCTGAATCCATTTGTCAGC
CATA,
reverse - ATGAAGGACAAGCTAAATTG),
HA (forward - GCTCTGGAGAACCAACATACAA,
reverse - ACAAGGGTGTTTTTAATTACTAATA),
PB2 (forward - CCACCCAGATAATAAAGCTTCT
CCCC,
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PA (forward - ATGACCAAAGAGTTTTTTGAGAATA,
reverse - GTATGGATAGCAAATAGTAGCATTG).Quantitative PCR
Equal amounts of cDNA were used in triplicate reactions.
Quantitative PCR reactions were run in the Applied
Biosystems StepOnePlus Real Time PCR system using
SYBR Green Master mix (Applied Biosystems), with
ROX as the reference dye.














PCR was performed in a standard 3 cycle PCR with de-
naturation at 95°C for 30 seconds, annealing temperature
of 55°C for 30 seconds, and extension temperature of 72°C
for 30 seconds.Statistical Analysis of qPCR Data
Raw CT values were analyzed in Microsoft Excel using
the 2ΔCt(control-treated) formula of 2^CTaverage Control sample/
2^ CTaverage Treated sample. Due to the robust host shut off
that occurs during influenza infection, we were unable
to reliably detect a reference gene but rather normalized
to total RNA concentration. RNA OD to calculate
concentration was taken in duplicate or triplicate and
RNA analyzed using gel electrophoresis prior to reverse
transcription to ensure equal rRNA concentration and no
RNA degradation. Reverse transcription reactions were
aliquot from a master mix to ensure all samples obtained
equivalent AMV-RT enzyme. Standard error was obtained
by calculating the standard deviation of the sample set
divided by the square root of the sample set size, and
indicated using error bars. Significance was determined
using a two-tailed T-Test conducted in Microsoft Excel,
and judging any p value less than .05 as significant.
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